alphaXRT

We’re hiring! Are you the Field Service Engineer we are looking for?

maxit — Mon, 23 Feb 2026 02:00:37 +0000

Outstanding opportunity to join alphaXRT, a leading supplier of radiation therapy equipment in Australia and New Zealand as a Field Service Engineer.

Positions available in Auckland, Sydney and Brisbane.

alphaXRT specialises in the marketing, sales, service and support of equipment used in the treatment of cancer, and for cancer research. Our state-of-the-art solutions include Accuray radiotherapy and radiosurgery systems. We are currently seeking Field Service Engineers to join our successful, clinically experienced team, with positions available in Auckland, Brisbane and Sydney.

Applicants with relevant experience in radiation therapy, and in particular with Accuray products, are encouraged to apply. Experience with the installation and service of high energy X-ray equipment is essential. Duties will include customer service and support, installations (including pre-installation planning), preventative maintenance, and on-site repair.

These roles will also include troubleshooting, repair and testing of quality assurance equipment returned to our premises. All service activities will require the timely completion of accurate service records and spare-parts inventories.

Domestic and international travel will be required.

Applicants must have good communication skills, be customer focused, and be able to develop strong relationships with our valued customer base.

The successful candidate will have:

– A tertiary qualification in a relevant engineering field

– Extensive experience in the service, repair, and installation of radiation therapy equipment, particularly Accuray TomoTherapy, Radixact and CyberKnife systems
– Experience in customer support, including direct customer communications

– Effective written skills

– Good understanding of ESD requirements
– A valid driving licence
– Experience with medical IT systems is an advantage

Please send your Cover Letter and CV to [email protected]

Applications accepted by 23 March 2026.

The post We’re hiring! Are you the Field Service Engineer we are looking for? appeared first on alphaXRT.

2026 Accuray Australasian Symposium

maxit — Mon, 09 Feb 2026 00:19:01 +0000

We’re excited to announce that the Accuray Australasian Symposium 2026 date is officially set — please save the date!

Saturday, 17^th October 2026

W Hotel, Brisbane, Australia

Join us for a day of knowledge sharing, collaboration, and innovation with leaders and professionals from across the Australasian region.

A call for abstracts and further details on our keynote speakers will be released soon — stay tuned for updates.

We look forward to welcoming you to Brisbane later this year.

The post 2026 Accuray Australasian Symposium appeared first on alphaXRT.

A new chapter is unfolding for cancer care across Australia and New Zealand as alphaXRT joins the EBOS MedTech portfolio.

maxit — Mon, 09 Feb 2026 00:17:00 +0000

A new chapter is unfolding for cancer care across Australia and New Zealand as alphaXRT joins the EBOS MedTech portfolio.

This acquisition strengthens how we support radiation oncology teams across Australia and New Zealand, bringing together precision technology, leading professional education and trusted local service and support, all focused on expanding access to care.

Read the full article to learn how alphaXRT fits within Life Healthcare and the broader EBOS MedTech platform, and what this means for clinicians, partners and patients here: https://www.ebosmedtech.com/articles/alphaxrt-joins-ebos-medtech/

The post A new chapter is unfolding for cancer care across Australia and New Zealand as alphaXRT joins the EBOS MedTech portfolio. appeared first on alphaXRT.

Dr. Giuseppe Sasso, a seasoned Radiation Oncologist

maxit — Wed, 18 Jun 2025 22:32:06 +0000

Dr. Giuseppe Sasso, a seasoned Radiation Oncologist with over three decades of global experience, is at the forefront of integrating artificial intelligence into clinical practice. Now based in New Zealand, Dr. Sasso has incorporated MVision AI’s Contour+ auto-segmentation tool into his workflow, applying it to both conventional linear accelerator treatments and advanced stereotactic procedures using CyberKnife. With a background that spans leadership roles in major oncology centers across Europe, the Middle East, and Australasia, Dr. Sasso brings a deeply informed, pragmatic perspective on the role of AI in modern radiation oncology. In this article, he shares his clinical experience using AI-driven tools to enhance contouring accuracy, streamline planning workflows, and improve patient care.

2025 Accuray Australasian Symposium

maxit — Thu, 08 May 2025 04:25:49 +0000

On 26^th October 2025, alphaXRT had the pleasure of hosting the Accuray Australasian Symposium, bringing together radiation therapy professionals, physicists, and clinical leaders from across Australia, New Zealand, and beyond.

It was an inspiring day of collaboration, innovation, and shared passion for advancing patient care. From in-depth discussions on the latest CyberKnife^® and Radixact^® technologies to real-world insights from clinics leading the way in adaptive and stereotactic treatments, the exchange of knowledge was exceptional.

A huge thank you to our guest speakers, partners at Accuray, and everyone who attended and contributed to making the event such a success. Your enthusiasm and expertise continue to drive the future of radiation oncology in our region.

We’re proud to support a community that’s constantly pushing the boundaries of precision, innovation, and patient outcomes.

Planning is already underway for the Accuray Australasian Symposium 2026!

The post 2025 Accuray Australasian Symposium appeared first on alphaXRT.

TAE Life Sciences Partners with alphaXRT to bring Boron Neutron Capture Therapy to Australia and New Zealand

bizdojo — Fri, 04 Apr 2025 01:44:48 +0000

TAE Life Sciences (TLS), a leader in next-generation Boron Neutron Capture Therapy (BNCT) solutions, has announced a distribution agreement with alphaXRT, to distribute TAE Life Sciences’ Alphabeam BNCT system and novel boron drugs, while also providing associated services across Australia and New Zealand.

As part of the agreement, alphaXRT will hold the regulatory certificate for BNCT in the region, ensuring compliance with local medical and regulatory standards. This collaboration will expand access to BNCT, offering patients with difficult-to-treat cancers an innovative and targeted radiation therapy option.

“This agreement with alphaXRT marks a significant step forward in making BNCT more accessible to patients in Australia and New Zealand,” said Rob Hill, CEO of TAE Life Sciences. “With alphaXRT’s deep expertise in radiation oncology and regulatory affairs, we are confident that this partnership will drive adoption and establish BNCT as a key treatment modality in the region.”

The Alphabeam BNCT system is a cutting-edge accelerator-based neutron source designed to deliver safe, effective, and precisely targeted radiation therapy. By leveraging boron-10 drugs, BNCT enables selective tumor destruction while preserving surrounding healthy tissue—making it a promising option for patients with recurrent or treatment-resistant cancers.

“TAE Life Sciences is at the forefront of BNCT innovation, and we are thrilled to be their distributor in Australia and New Zealand,” said Richard Neale, Managing Director of alphaXRT. “We look forward to working closely with hospitals and cancer treatment centers to bring this transformative therapy to more patients.”

This partnership further underscores TAE Life Sciences’ commitment to expanding global access to BNCT and advancing the future of radiation oncology.

The post TAE Life Sciences Partners with alphaXRT to bring Boron Neutron Capture Therapy to Australia and New Zealand appeared first on alphaXRT.

Icon Cancer Centre and 5D Clinics: A Joint Venture to Expand Access to Advanced Radiotherapy in Australia

bizdojo — Tue, 25 Mar 2025 21:49:08 +0000

In a move to increase patient access to advanced radiotherapy technology, Icon Cancer Centre has partnered with 5D Clinics to bring the highly precise Accuray CyberKnife® System to the east coast of Australia. This joint venture aims to make robotic radiation therapy technology available to the greater Australian population, reducing the current need to travel long-distances and associated physical and emotional stress. The first of these new eastern seaboard CyberKnife centres is located in Cremorne, Melbourne and is the first of several clinics planned across Australia’s east coast through the partnership¹.

In the year 2000, approximately 88,000 cases of cancer were diagnosed in Australia. Projections indicated that in 2024, the number of cancer diagnoses rose to around 169,000, representing an increase of approximately 93% over 24 years. This significant increase is primarily attributed to population growth and the rising number of individuals reaching older age, where cancer incidence rates are higher. By 2034, with continued population growth and an anticipated increase in cancer rates, it is estimated that approximately 209,000 cases of cancer will be diagnosed in Australia².

Radiotherapy is an extremely important treatment for cancer patients, delivered with the aim to prevent or cure disease, or as palliative care. Between 2018-2019, 74,200 courses of radiotherapy were delivered in Australia³.

A recent report from the Lancet Oncology Commission on Radiotherapy and Theranostics found that despite progress, a disparity in equipment availability and a lack of trained medical professionals remains as a global challenge. By 2050, the radiation therapy workforce will need to expand significantly to meet the projected rise in cancer cases. To mitigate this, the Commission suggests optimizing workflows, using resource-sparing approaches, and adopting advanced techniques. Implementing hypofractionation for prostate and breast cancer has the potential to provide radiotherapy for an additional 2.2 million patients with significant associated cost savings. Stereotactic body radiation therapy (SBRT) is also cost-effective, even in low- and middle-income countries⁴.

Click here to read the full blog including interview with Bruno Bosco, GM of the new CyberKnife Centre, Joint Venture of Icon and 5D Clinics.

The post Icon Cancer Centre and 5D Clinics: A Joint Venture to Expand Access to Advanced Radiotherapy in Australia appeared first on alphaXRT.

Nick Evans joins alphaXRT

bizdojo — Mon, 03 Mar 2025 01:40:18 +0000

We are delighted to introduce our newly appointed Chief Commercial Officer, Nick Evans, who joins the alphaXRT team on Monday 3 March.

Nick brings with him a wealth of experience in global and local medical device sales, operations and management. Known for bringing new energy into organisations, Nick is passionate about improving lives through innovative medical device products, and has a goal to build motivated teams that are inspired by the work they do each day.

The post Nick Evans joins alphaXRT appeared first on alphaXRT.

2024 Accuray Australasian Symposium

maxit — Tue, 20 Feb 2024 10:11:46 +0000

The Accuray Australasian Symposium is back!

Join us on Sunday 20th October 2024 at The Westin Hotel Perth, as we host this exceptional event in conjunction with 5D Clinics and Sir Charles Gairdner Hospital.

Symposium highlights will include:

User presentations
International guest speaker Dr Joost Nuyttens – Assistant Professor and Radiation Oncologist at Erasmus Medical Center
Plenty of opportunities for discussion with other users and the alphaXRT/Accuray teams

Register now to secure your place for this event.

The post 2024 Accuray Australasian Symposium appeared first on alphaXRT.

2023 Accuray Australasian Symposium

bizdojo — Thu, 16 Nov 2023 21:33:59 +0000

Our 2023 Accuray Australasian Symposium was a great success with 60 delegates attending the event which was held at the W Hotel in conjunction with the Royal Brisbane & Women’s Hospital. We would like to thank the RBWH team, all our guest speakers and Accuray for making this such a successful and rewarding event. Particular thanks also to our inspirational international guest speakers, Dr Sean Collins, Director of the CyberKnife Prostate Program at Medstar Georgetown University Hospital and Dr Seth Blacksburg, Chief Medical Officer at Accuray. We are looking forward to next year’s Symposium – this will be in Perth on 20^th October 2024, save the date!

The post 2023 Accuray Australasian Symposium appeared first on alphaXRT.